Moss, MD, Ronald B., Fiona Carleton, PhD, Charles P. Lollo, PhD, and Dennis J. Carlo, PhD. 2020. “An Open-Label, Randomized, Single-Dose, Two-Period, Two-Treatment Crossover Bioavailability Study Comparing 5 mg/0.5 ML of Intramuscular Naloxone Hydrochloride to 2 mg/0.4 ML Intramuscular Naloxone Hydrochloride Autoinjector in Healthy Subjects”. Journal of Opioid Management 16 (3):209-14. https://doi.org/10.5055/jom.2020.0569.